2 completed, 2 terminated. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow Avera Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity AV608 - Overactive Bladder Syndrome | Phase 2 | Terminated | Avera Pharmaceuticals | 62 | 2006-06-01 | 2008-02-25 |
| Pilot Study to Assess the Effects of AV608 on Irritable Bowel Syndrome AV608 - Irritable Bowel Syndrome (IBS) | Phase 1 | Terminated | Avera Pharmaceuticals | 24 | 2006-04-01 | 2008-02-25 |
| Safety and Efficacy Study of AV608 in Subjects With Social Anxiety Disorder AV608 - Social Phobia | Phase 2 | Completed | Avera Pharmaceuticals | 180 | 2006-02-01 | 2008-02-25 |
| The Efficacy and Safety of Gantacurium Chloride for Injection in Tracheal Intubation in Healthy Adult Patients Undergoing Surgery Under General Anesthesia Gantacurium Chloride for Injection (AV430A) - Healthy | Phase 1 / Phase 2 | Completed | Avera Pharmaceuticals | 200 | 2005-05-01 | 2006-07-21 |
Irritable Bowel Syndrome (1) · Phobia, Social (1) · Urinary Bladder, Overactive (1) · Urinary Incontinence, Urge (1)
Injections (1)
United States (2) · Germany (1) · Netherlands (1) · United Kingdom (1)
Joao Siffert, MD (2) · Jorgen Viby-Mogensen, MD (1) · Kirsten Tillisch, MD (1) · Linda Cardozo, MD FRCOG (1) · Manfred Blobner, MD (1)